Gene expression profiling of meningiomas: Current status after a decade of microarray-based transcriptomic studies

Acta Neurochirurgica

Volumn 153, Issue 3, 2011, Pages 447-456

  Aarhus, Mads ^a,b   Lund Johansen, Morten ^a,b   Knappskog, Per Morten ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Gene expression profiling; Meningioma; Microarray analysis; Oligonucleotide array sequence analysis

Indexed keywords

MESSENGER RNA;

CANCER GRADING; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MENINGIOMA; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA HYBRIDIZATION; TRANSCRIPTOMICS;

GENE EXPRESSION PROFILING; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATHOLOGY, MOLECULAR; PROGNOSIS;

EID: 79952533504     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-010-0906-0     Document Type: Review

References (29)

1. Ramaswamy S (2004) Translating cancer genomics into clinical oncology. N Engl J Med 350:1814-1816
2. Mischel PS, Cloughesy TF, Nelson SF (2004) DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 5:782-792 (Pubitemid 39336215)
3. Stekel D (2003) Microarray bioinformatics. Cambridge University Press, Cambridge
4. OH LDN, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. World Health Organization IARC, Lyon
5. Arai E, Ikeuchi T, Karasawa S, Tamura A, Yamamoto K, Kida M, Ichimura K, Yuasa Y, Tonomura A (1992) Constitutional translocation t(4, 22) (q12;q12.2) associated with neurofibromatosis type 2. Am J Med Genet 44:163-167
6. Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Superneau DW, Martuza RL, Gusella JF (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46:323-328
7. Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 319:278-283
8. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 51:478-485
9. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9:296-298 (Pubitemid 24114835)
10. Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA (1999) Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg 91:85-92
11. Peyrard M, Pan HQ, Kedra D, Fransson I, Swahn S, Hartman K, Clifton SW, Roe BA, Dumanski JP (1996) Structure of the promoter and genomic organization of the human beta'-adaptin gene (BAM22) from chromosome 22q12. Genomics 36:112-117 (Pubitemid 26277764)
12. Zucman-Rossi J, Legoix P, Thomas G (1996) Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics 38:247-254 (Pubitemid 27030111)
13. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
14. Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161:665-672 (Pubitemid 36142175)
15. Sasaki T, Hankins GR, Helm GA (2003) Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip. Neurosurgery 52:892-898, discussion 898-899
16. Fathallah-Shaykh HM, He B, Zhao LJ, Engelhard HH, Cerullo L, Lichtor T, Byrne R, Munoz L, Von Roenn K, Rosseau GL, Glick R, Sherman C, Farooq K (2003) Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 278:23830-23833 (Pubitemid 36830208)
17. Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114:249-256 (Pubitemid 40194294)
18. Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121-7126 (Pubitemid 41161241)
19. Sayagues JM, Tabernero MD, Maillo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de AE G-M, MC OA (2006) Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65:445-454 (Pubitemid 44297266)
20. Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A (2007) Molecular signatures define two main classes of meningiomas. Mol Cancer 6:64
21. Aarhus M, Bruland O, Bredholt G, Lybaek H, Husebye ES, Krossnes BK, Vedeler C, Wester K, Lund-Johansen M, Knappskog PM (2008) Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. J Neurooncol 88(3):251-259
22. Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK (2008) Radiation-induced meningiomas: clinical, cytogenetic, and microarray features. Acta Neuropathol 116:289-301
23. Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771-780, discussion 780-771
24. Claus EB, Park PJ, Carroll R, Chan J, Black PM (2008) Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314-322 (Pubitemid 351380134)
25. Fevre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J, Jouvet A (2009) Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 35:1395-1407
26. Castells X, Garcia-Gomez JM, Navarro A, Acebes JJ, Godino O, Boluda S, Barcelo A, Robles M, Arino J, Arus C (2009) Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling. Diagn Mol Pathol 18:206-218
27. Shi L, Tong W, Fang H, Scherf U, Han J, Puri RK, Frueh FW, Goodsaid FM, Guo L, Su Z, Han T, Fuscoe JC, Xu ZA, Patterson TA, Hong H, Xie Q, Perkins RG, Chen JJ, Casciano DA (2005) Cross-platform comparability of microarray technology: intraplatform consistency and appropriate data analysis procedures are essential. BMC Bioinform 6(Suppl 2):S12
28. Sotiriou C, Piccart MJ (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7:545-553
29. Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008). Nature 455(7216):1061-1068